Baltimore, MD, United States of America

Daniel Lucena Comingues

This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Daniel Lucena Comingues

Introduction

Daniel Lucena Comingues is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of novel therapeutic delivery systems. His work focuses on creating innovative solutions that enhance the efficacy of protein therapeutics.

Latest Patents

Daniel holds a patent for "Polymeric nanoparticle compositions for encapsulation and sustained release of protein therapeutics." This patent describes new biodegradable nanoparticle platforms designed for the encapsulation and sustained release of protein therapeutics through a scalable and reproducible method. The nanoparticles comprise a complex that includes a protein or peptide and a counter ion polymer, showcasing a significant advancement in drug delivery technology.

Career Highlights

Daniel is affiliated with Johns Hopkins University, where he engages in cutting-edge research and development. His work at this prestigious institution allows him to collaborate with leading experts in the field and contribute to groundbreaking innovations in healthcare.

Collaborations

Daniel has worked alongside notable colleagues such as Hai-Quan Mao and Sashank Reddy. Their collaborative efforts have furthered research in the area of nanoparticle technology and its applications in medicine.

Conclusion

Daniel Lucena Comingues exemplifies the spirit of innovation in the biomedical field through his patent and research endeavors. His contributions are paving the way for advancements in therapeutic delivery systems, ultimately benefiting patient care and treatment outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…